Last reviewed:
Yes. Many people with HIV travel internationally safely while continuing treatment. Entry, visa and medicine-import rules vary with the destination, transit stops and purpose of travel. Check current country guidance before booking, confirm any requirements with the relevant authorities, and plan medication supplies and travel health care with your clinician.[1][2][4][7][8]
The legal landscape: mostly open, with real exceptions
The United States is itself an example of change. UNAIDS reported that travellers living with HIV could freely enter the U.S. as of 4 January 2010, overturning a policy in place since 1987, after the change was announced in October 2009[5]. Most of the world is open: UNAIDS's own accounting found 203 countries, territories and areas with no HIV-related restrictions on entry, stay and residence, while 48 imposed some form of restriction as of June 2019[3]. CDC's current traveler guidance puts the figure at approximately 50 countries that still require HIV testing or restrict entry, stay, or residence based on HIV status[1].
Use the UNAIDS country database and Positive Destinations as starting points, then confirm requirements for your itinerary with the destination’s immigration or consular authorities. U.S. travelers can also ask the U.S. embassy or consulate in that country. A database entry is not a guarantee of entry or a substitute for the rules applying to your visa.[7][8][1][4]
UNAIDS's position on these laws is unequivocal: there is "no evidence that HIV-related travel restrictions protect public health," they fuel stigma, they may impair access to antiretroviral therapy, and in 2016 UN Member States agreed to eliminate them. UNAIDS also notes that countries which lifted restrictions "have found no need to re-adopt such measures"[3].
What kind of restriction, and how to verify
Two things determine whether a rule touches you: the country, and the length and purpose of your stay. CDC notes that for long-term stays — often more than 90 days, or those requiring a residency or work permit — medical documentation including HIV status may be required, whereas such requirements are uncommon for short business or tourist stays[1].
Restrictions can concern entry, study, work, residence or deportation. UNAIDS’s June 2019 explainer counted 19 countries or areas with HIV-related deportation rules and 18 requiring testing or disclosure for particular permits. Those are historical categories, not a current country-by-country checklist. Rules may differ for a short visit and a work or residency application. Employer practices and confidentiality protections also matter.[3][1]
Check both your destination and any transit country where you pass through customs. Confirm permitted medicines, quantities, paperwork and any advance approval. A U.S. prescription or clinician’s letter does not override another country’s import rules.[8][4][2]
Your medicine: packing, paperwork, and privacy
CDC's guidance is concrete: carry HIV medications in their original packaging with labels identifying medication, dosing and patient information; bring at least a few extra days' supply; and keep medications and supplies in carry-on luggage whenever possible[1]. Providers should also supply an official letter outlining prescribed medications and any required medical equipment[1]. NIH adds that prescription medicine should be in original packaging labeled with the dosage, your name and your date of birth, and that you can ask your provider for a letter listing medications, generic names and dosing[2].
A clinician can sometimes describe treatment as being for a medical condition without naming HIV. Ask whether that wording meets the destination’s documentation requirements. It does not remove a requirement to answer a visa or health question accurately. HIV medicines can reveal a person’s status, and some countries restrict entry or residence on that basis. Get country-specific advice before travel if disclosure or medication import is a concern.[7][8][1][2]
For longer trips, CDC suggests identifying a place at your destination to access HIV care, increasing a prescription from a 30-day to a 90-day supply in advance, and being aware that some countries limit the quantity of medicine you may import[1].
Time zones, doses, and staying suppressed on the road
Travel is a classic adherence trap, and NIH names it directly: changes in time zone, jet lag, long flights and busy schedules "can keep you from taking your medicine on time," and if you cross time zones "you may need to adjust the time at which you take your HIV medicine"[2]. The right move is to plan the shift with a professional rather than improvising at the gate: ask your health care provider or pharmacist how to time your dosing when traveling, especially for long flights[2].
NIH's practical protections: bring enough medicine for the whole trip plus a few extra days in case of delays, keep it in your carry-on so lost checked baggage does not cost you doses, and if needed, work with your provider to obtain HIV medicines in another location[2].
Food and water precautions travel with you. CDC advises people with HIV to avoid food- and waterborne infections such as Campylobacter, Cryptosporidium, E. coli, Giardia, Listeria, Salmonella and Shigella — through thorough handwashing, boiled, treated or bottled water where sanitation is inadequate, well-cooked hot food, and avoiding unpasteurized dairy — while noting that routine antimicrobial prophylaxis for bacterial enteric illness is not recommended[1]. NIH likewise advises avoiding tap water, ice, and drinks made with unheated tap water where water may be contaminated[2].
The pre-travel visit: vaccines, insurance, and PEP awareness
Arrange a travel-health appointment several months ahead when possible. Vaccine choice depends on the destination, immune status and vaccine type; a CD4 count of 200 or more does not make every live vaccine appropriate. MMR and varicella have specific eligibility criteria, and yellow fever vaccination requires individual assessment. If yellow fever vaccination is contraindicated, a clinician may issue a waiver, but the destination may refuse it. Confirm acceptance in advance and discuss changing the itinerary. Also review malaria prevention and mosquito protection; low CD4 counts and pregnancy warrant particular caution.[9][1]
Check whether your health plan covers care abroad, including HIV-related care and emergency transport. Medicare and Medicaid generally offer little or no routine foreign coverage, with limited exceptions. If buying travel insurance, confirm coverage for pre-existing conditions and medical evacuation before paying. Carry policy details and emergency contact information.[2][1]
If an HIV-negative companion may need PEP after a possible exposure, seek urgent clinical evaluation. CDC recommends starting as soon as possible, ideally within 24 hours and no later than 72 hours when indicated, then taking the prescribed regimen for 28 days. Identify possible treatment services before travel; do not wait for a routine appointment after an exposure.[10][6]
Research local laws and safety considerations affecting same-sex relationships using current destination guidance. For advanced or poorly controlled HIV, discuss whether delaying a trip until immune recovery and viral suppression would reduce infection risk. The decision depends on health, destination and the urgency of travel.[2][1]
Related questions
Will I be turned away at the border because of HIV?
Do I have to declare my HIV status?
Disclosure and testing requirements depend on the country and visa. A clinician may be able to write a medication letter without naming HIV, but it must meet the applicable requirements and does not permit inaccurate answers on official forms. Medicines themselves may reveal HIV status; seek country-specific advice before departure.[1][2][7][8]
How do I handle doses across time zones?
What if my luggage is lost or my trip is delayed?
Carry enough prescribed medicine for the trip and possible delays in original labeled containers, usually in hand luggage. Check import limits and arrange access to a reputable clinic or pharmacy before a long stay. Contact your care team promptly if medicine is lost or damaged; do not assume mailing replacements is permitted.[1][2][8]
Related from RiseUpToHIV
References & Sources
- CDC Yellow Book — Travelers with HIV. Primary clinical travel guidance: ~50 restricting countries, medication packing and privacy, vaccines, malaria, and insurance. ↩ ↩ ↩ ↩ ↩ ↩ ↩ ↩ ↩ ↩ ↩ ↩ ↩ ↩ ↩ ↩ ↩ ↩ ↩ ↩
- NIH HIVinfo — Traveling Safely With HIV. Disclosure, labeled packaging and provider letters, time-zone dosing, water safety, insurance, and local laws. ↩ ↩ ↩ ↩ ↩ ↩ ↩ ↩ ↩ ↩ ↩ ↩ ↩
- UNAIDS — Still Not Welcome: historical HIV-related travel restrictions, data as of June 2019. Source. ↩↩↩
- UNAIDS — HIV-related travel restrictions database: country information to cross-check with current official requirements. Source. ↩↩ ↩ ↩
- UNAIDS — Removal of U.S. entry restrictions based on HIV status (4 January 2010). The U.S. lifted its HIV entry ban on 4 January 2010, ending a policy in place since 1987. ↩
- CDC — PEP (Post-Exposure Prophylaxis). PEP must be started within 72 hours of exposure and is taken daily for 28 days; for emergency use only. ↩
- HIV Justice Network — Positive Destinations: travel and relocation information, formerly hivtravel.org. Source. Checked September 21, 2026. ↩ ↩ ↩ ↩ ↩
- CDC Yellow Book — Traveling With Prohibited or Restricted Medications. Source. Checked September 21, 2026. ↩ ↩ ↩ ↩ ↩ ↩ ↩
- CDC Yellow Book — Yellow Fever: contraindications, precautions and medical-waiver limits. Source. Checked September 21, 2026. ↩
- CDC MMWR — Nonoccupational PEP recommendations, 2025. Source. Checked September 21, 2026. ↩
Community publications like POZ, Positively Aware, and TheBody inform framing and lived-experience context on RiseUpToHIV. Every clinical, epidemiological, or public-health claim above is anchored to a primary source.